This suggests that the blockade of GLUT1 may prove efficacious in reversing the Warburg effect in GBM, particularly if it can be targeted in a tissue-specific fashion that avoids the blockade of GLUT1 throughout non-neoplastic tissue. This evidence concerns the gene SLC2A1 and glioblastoma.